Gregory Ginger's Form 4 filing
Biogen Inc.BIIB · filed Dec 12, 2022
- Accession no.
- 0001127602-22-027348
- Filed
- Dec 12, 2022
- Trade date
- Nov 14, 2022
- Filing delay
- 28 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market sales total $1.68M. It was filed 28 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gregory GingerCIK 0001545716 | Officer (EVP, Human Resources) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 14, 2022 | Common Stock | SSaleDisposed | −5,610 | $300.11 | −$1,683,617.1 | 5,711.02 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.